Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2023-04-14 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司第十届监事会第十次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Liaoning Chengda Co., Ltd. regarding their 10th meeting of the 10th Supervisory Board. It includes the Supervisory Board's review and opinions on the company's 2022 annual report, audit report, profit distribution plan, internal control evaluation report, social responsibility report, and other related matters. The document references the 2022 annual report and audit report but does not contain the full annual report or detailed financial statements itself. It also mentions that these reports are available on the Shanghai Stock Exchange website. The document is relatively short (2446 characters) and serves as an official announcement of the Supervisory Board's resolutions and opinions on various reports and proposals, many of which require shareholder approval. This fits the profile of a Regulatory Filing (RNS) as it is a formal regulatory announcement about supervisory board decisions and opinions rather than the full annual report or audit report itself.
2023-04-14 Chinese
辽宁成大股份有限公司关于向广发证券股份有限公司购买理财产品暨关联交易公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction where the company plans to purchase financial products from a related securities company. It includes details about the transaction, approval procedures, independent directors' opinions, and financial data of the related party. The document is relatively short (2049 characters) and focuses on disclosing a specific transaction rather than presenting comprehensive financial statements or performance data. It does not contain full financial reports or earnings data, nor is it a meeting presentation or voting result. Therefore, it fits best as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-04-14 Chinese
辽宁成大股份有限公司董事会审计委员会2022年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a report on the 2022 annual performance of the Board Audit Committee of Liaoning Chengda Co., Ltd. It details the committee members, meetings held during 2022, their oversight of the 2021 annual audit, supervision of the external audit firm, internal control implementation, and review of related party transactions. The content is focused on the audit committee's activities and their fulfillment of duties during the year, rather than presenting full financial statements or a complete annual report. The document length is 3260 characters, which is relatively short and consistent with a committee report rather than a full annual report or audit report. It is not a certification or a brief announcement but a detailed committee report on audit-related governance and oversight. Therefore, the document fits best under the category of Audit Report / Information (AR), which includes standalone audit reports and related committee reports on audit activities and internal controls, excluding full annual reports. FY 2022
2023-04-14 Chinese
辽宁成大股份有限公司独立董事关于第十届董事会第十七次会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is an independent directors' pre-approval opinion regarding matters to be discussed at the 17th meeting of the 10th board of directors of Liaoning Chengda Co., Ltd. It discusses related party transactions and the appointment of the 2023 financial audit and internal control audit institutions. The document references compliance with laws and internal regulations and expresses the independent directors' agreement to submit these matters to the board for approval. It is not a full audit report, annual report, or financial statement, but rather a board/management related announcement concerning governance and board meeting matters. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification letter, so it is not RPA or RNS.
2023-04-14 Chinese
辽宁成大股份有限公司2022年年度报告摘要
Annual Report Classification · 100% confidence The document is titled '辽宁成大股份有限公司 2022 年年度报告摘要' which translates to 'Liaoning Chengda Co., Ltd. 2022 Annual Report Summary'. It contains detailed financial data for the year 2022, including total assets, net profit, revenue, quarterly financial data, shareholder information, bond information, and business segment performance. The document includes comprehensive financial statements and analysis for the full fiscal year 2022. It is not a brief announcement or a certification but a substantive financial report covering the company's yearly performance. Therefore, it fits the definition of an Annual Report (10-K). FY 2022
2023-04-14 Chinese
辽宁成大股份有限公司第十届董事会第十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 17th meeting of the 10th Board of Directors of Liaoning Chengda Co., Ltd. It includes voting results on various agenda items such as the 2022 annual president's business report, board work report, annual report, financial statements, profit distribution, internal control reports, social responsibility report, remuneration of directors and senior management, and other corporate governance matters. The document repeatedly states that these reports and proposals will be submitted to the shareholders' meeting for approval and references other announcements for detailed information. The document is not the annual report itself but a board meeting resolution announcement. It is also not a proxy statement or voting results announcement since it is about board meeting decisions, not shareholder votes. The document length is 3240 characters, which is relatively short and consistent with a board meeting resolution announcement. Therefore, the best fitting category is Board/Management Information (MANG).
2023-04-14 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.